206 related articles for article (PubMed ID: 27109485)
41. Comparative study of methods for determining vascular permeability and blood volume in human gliomas.
Harrer JU; Parker GJ; Haroon HA; Buckley DL; Embelton K; Roberts C; Balériaux D; Jackson A
J Magn Reson Imaging; 2004 Nov; 20(5):748-57. PubMed ID: 15503330
[TBL] [Abstract][Full Text] [Related]
42. A novel method for analyzing DSCE-images with an application to tumor grading.
Slotboom J; Schaer R; Ozdoba C; Reinert M; Vajtai I; El-Koussy M; Kiefer C; Zbinden M; Schroth G; Wiest R
Invest Radiol; 2008 Dec; 43(12):843-53. PubMed ID: 19002056
[TBL] [Abstract][Full Text] [Related]
43. Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers.
Awasthi R; Rathore RK; Soni P; Sahoo P; Awasthi A; Husain N; Behari S; Singh RK; Pandey CM; Gupta RK
Neuroradiology; 2012 Mar; 54(3):205-13. PubMed ID: 21541688
[TBL] [Abstract][Full Text] [Related]
44. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging.
Provenzale JM; Wang GR; Brenner T; Petrella JR; Sorensen AG
AJR Am J Roentgenol; 2002 Mar; 178(3):711-6. PubMed ID: 11856703
[TBL] [Abstract][Full Text] [Related]
45. Association of Glioma Grading With Inflow-Based Vascular-Space-Occupancy MRI: A Preliminary Study at 3T.
Li X; Liao S; Hua J; Guo L; Wang D; Xiao X; Zhou J; Liu X; Tan Y; Lu L; Xu Y; Wu Y
J Magn Reson Imaging; 2019 Dec; 50(6):1817-1823. PubMed ID: 30932289
[TBL] [Abstract][Full Text] [Related]
46. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps.
Emblem KE; Nedregaard B; Nome T; Due-Tonnessen P; Hald JK; Scheie D; Borota OC; Cvancarova M; Bjornerud A
Radiology; 2008 Jun; 247(3):808-17. PubMed ID: 18487536
[TBL] [Abstract][Full Text] [Related]
47. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI.
Sahoo P; Rathore RK; Awasthi R; Roy B; Verma S; Rathore D; Behari S; Husain M; Husain N; Pandey CM; Mohakud S; Gupta RK
J Magn Reson Imaging; 2013 Sep; 38(3):677-88. PubMed ID: 23390002
[TBL] [Abstract][Full Text] [Related]
48. Automatic vessel removal in gliomas from dynamic susceptibility contrast imaging.
Emblem KE; Due-Tonnessen P; Hald JK; Bjornerud A
Magn Reson Med; 2009 May; 61(5):1210-7. PubMed ID: 19253390
[TBL] [Abstract][Full Text] [Related]
49. Glioma Angiogenesis and Perfusion Imaging: Understanding the Relationship between Tumor Blood Volume and Leakiness with Increasing Glioma Grade.
Jain R; Griffith B; Alotaibi F; Zagzag D; Fine H; Golfinos J; Schultz L
AJNR Am J Neuroradiol; 2015 Nov; 36(11):2030-5. PubMed ID: 26206809
[TBL] [Abstract][Full Text] [Related]
50. Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.
Sunwoo L; Choi SH; Yoo RE; Kang KM; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Park SW; Sohn CH; Won JK; Park SH; Kim IH
Neuroradiology; 2015 Nov; 57(11):1111-20. PubMed ID: 26232204
[TBL] [Abstract][Full Text] [Related]
51. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
[TBL] [Abstract][Full Text] [Related]
52. Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.
Conte GM; Castellano A; Altabella L; Iadanza A; Cadioli M; Falini A; Anzalone N
Radiol Med; 2017 Apr; 122(4):294-302. PubMed ID: 28070841
[TBL] [Abstract][Full Text] [Related]
53. Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study.
Di N; Cheng W; Jiang X; Liu X; Zhou J; Xie Q; Chu Z; Chen H; Wang B
J Neuroradiol; 2019 May; 46(3):186-192. PubMed ID: 29752976
[TBL] [Abstract][Full Text] [Related]
54. Quantification of cerebral tumour blood flow and permeability with T1-weighted dynamic contrast enhanced MRI: a feasibility study.
Dujardin MI; Sourbron SP; Chaskis C; Verellen D; Stadnik T; de Mey J; Luypaert R
J Neuroradiol; 2012 Oct; 39(4):227-35. PubMed ID: 21840059
[TBL] [Abstract][Full Text] [Related]
55. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
Hu LS; Kelm Z; Korfiatis P; Dueck AC; Elrod C; Ellingson BM; Kaufmann TJ; Eschbacher JM; Karis JP; Smith K; Nakaji P; Brinkman D; Pafundi D; Baxter LC; Erickson BJ
AJNR Am J Neuroradiol; 2015 Dec; 36(12):2242-9. PubMed ID: 26359151
[TBL] [Abstract][Full Text] [Related]
56. Bayesian modeling of Dynamic Contrast Enhanced MRI data in cerebral glioma patients improves the diagnostic quality of hemodynamic parameter maps.
Tietze A; Nielsen A; Klærke Mikkelsen I; Bo Hansen M; Obel A; Østergaard L; Mouridsen K
PLoS One; 2018; 13(9):e0202906. PubMed ID: 30256797
[TBL] [Abstract][Full Text] [Related]
57. Glioma grading by dynamic susceptibility contrast perfusion and
Brendle C; Hempel JM; Schittenhelm J; Skardelly M; Reischl G; Bender B; Ernemann U; la Fougère C; Klose U
Neuroradiology; 2018 Apr; 60(4):381-389. PubMed ID: 29464269
[TBL] [Abstract][Full Text] [Related]
58. PDZK1 is correlated with DCE-MRI perfusion parameters in high-grade glioma.
Zhang Y; Wang F; Huang Y
Clinics (Sao Paulo); 2024; 79():100367. PubMed ID: 38692010
[TBL] [Abstract][Full Text] [Related]
59. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
[TBL] [Abstract][Full Text] [Related]
60. Predicting grade of cerebral glioma using vascular-space occupancy MR imaging.
Lu H; Pollack E; Young R; Babb JS; Johnson G; Zagzag D; Carson R; Jensen JH; Helpern JA; Law M
AJNR Am J Neuroradiol; 2008 Feb; 29(2):373-8. PubMed ID: 17974612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
